St John's wort (Hypericum perforatum): drug interactions and clinical outcomes (Q34976869)

5 August 2017

1 reference

title

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes (English)

1 reference

5 August 2017

0 references

L Henderson

1

1 reference

5 August 2017

Q Y Yue

2

1 reference

5 August 2017

C Bergquist

3

1 reference

5 August 2017

B Gerden

4

1 reference

5 August 2017

P Arlett

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

British Journal of Clinical Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

54

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

349-356

1 reference

Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

St. John's wort and antidepressant drug interactions in the elderly

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Human P450 metabolism of warfarin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Side-effects of antidepressants.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Hypericin and its photodynamic action

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

The role of cytochromes P-450 in cyclosporine metabolism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Metabolism of 17 alpha-ethynylestradiol in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874438

Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant Activity

8 July 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.2002.01683.X

Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.2002.01683.X

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.2002.01683.X

Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.2002.01683.X

Second thoughts about safety of St John's wort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.2002.01683.X

Potential metabolic interaction between St. John's wort and theophylline

21 January 2018

1 reference

12 December 2020

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

1 reference

12 December 2020

Acute heart transplant rejection due to Saint John's wort

1 reference

12 December 2020

Safety of St John's wort (Hypericum perforatum)

1 reference

12 December 2020

Contraceptive effectiveness: cytochromes and induction

1 reference

12 December 2020

Profound drop of cyclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum)

1 reference

12 December 2020

Drug interaction between St. John's wort and cyclosporine

1 reference

12 December 2020

An investigation of the type of photosensitization caused by the ingestion of St John's Wort (Hypericum perforatum) by calves

1 reference

12 December 2020

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients

1 reference

12 December 2020

Effects of hypericum extract on the expression of serotonin receptors

1 reference

12 December 2020

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

1 reference

12 December 2020

Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitors

1 reference

12 December 2020

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

1 reference

12 December 2020

SSRIs and St.John's Wort: possible toxicity?

1 reference

12 December 2020

Hypericum perforatum (St John's wort) in depression: pest or blessing?

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01683.X

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference